Agranulocytosis and hydroxychloroquine.
D000380:Agranulocytosis / Q000139:chemically induced*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006886:Hydroxychloroquine / Q000009:adverse effects*; D011241:Prednisone / Q000627:therapeutic use; D013203:Staphylococcal Infections; D014481:United States; D014486:United States Food and Drug Administration
D006886:Hydroxychloroquine; D011241:Prednisone